Insider Selling: Ambev (NYSE:ABEV) Director Sells $1,441,563.20 in Stock

Ambev S.A. (NYSE:ABEV) Director Ricardo Manuel Frangat Moreira sold 468,040 shares of the firm’s stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $3.08, for a total value of $1,441,563.20. Following the completion of the sale, the director directly owned 3,000,000 shares of the company’s stock, valued at $9,240,000. This trade represents a 13.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Ambev Trading Down 0.8%

Shares of ABEV stock traded down $0.03 on Friday, hitting $3.10. 57,167,504 shares of the stock traded hands, compared to its average volume of 25,950,451. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.78 and a current ratio of 1.03. Ambev S.A. has a twelve month low of $2.10 and a twelve month high of $3.45. The firm’s 50-day moving average price is $3.13 and its two-hundred day moving average price is $3.03. The stock has a market capitalization of $48.78 billion, a PE ratio of 16.29, a PEG ratio of 1.81 and a beta of 0.64.

Ambev (NYSE:ABEV) last issued its earnings results on Thursday, July 30th. The company reported $0.04 EPS for the quarter, hitting analysts’ consensus estimates of $0.04. Ambev had a net margin of 17.69% and a return on equity of 16.63%. The company had revenue of $3.89 billion for the quarter, compared to the consensus estimate of $4.05 billion. As a group, analysts anticipate that Ambev S.A. will post 0.2 EPS for the current year.

Ambev Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 11th. Stockholders of record on Wednesday, June 24th will be issued a dividend of $0.0092 per share. The ex-dividend date is Wednesday, June 24th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.2%. Ambev’s dividend payout ratio is currently 10.53%.

Trending Headlines about Ambev

Here are the key news stories impacting Ambev this week:

• Positive Sentiment: Ambev’s board approved approximately R$2.7 billion in interest-on-capital payments for 2026, including the third and final installment. The payout supports the stock’s income appeal and signals continued cash-return capacity. Ambev Approves R$2.7 Billion in Interest on Capital Payments for 2026
• Positive Sentiment: The brewer is preparing for hotter conditions associated with El Niño. Warmer weather could support demand for beer and other beverages, although the eventual effect will depend on regional weather patterns and operating costs. Ambev se prepara para clima mais quente com El Niño
• Neutral Sentiment: Barclays reaffirmed its Hold rating, indicating the analyst does not see a sufficiently compelling near-term catalyst to change its stance. Barclays Reaffirms Their Hold Rating on Ambev SA
• Neutral Sentiment: Ambev filed its July Form 6-K, reaffirming its U.S. reporting status. The filing is a routine compliance update with limited direct effect on valuation. Ambev July 2026 Form 6-K
• Negative Sentiment: Ambev’s latest results were mixed: adjusted EPS of $0.04 met consensus, but revenue of $3.89 billion fell short of the $4.05 billion estimate. The top-line miss is the clearest reason for investor pressure, suggesting weaker-than-expected sales momentum despite earnings execution. Ambev Q2 2026 Earnings Call Transcript

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Wall Street Zen lowered shares of Ambev from a “buy” rating to a “hold” rating in a research note on Monday, July 13th. Scotiabank cut shares of Ambev from a “sector outperform” rating to a “sector perform” rating in a research report on Wednesday, July 15th. Weiss Ratings lowered Ambev from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, May 6th. UBS Group raised their price target on Ambev from $2.65 to $2.90 and gave the stock a “sell” rating in a research report on Thursday, May 14th. Finally, Barclays boosted their price objective on Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a report on Wednesday, May 6th. Six analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $3.09.

Institutional Investors Weigh In On Ambev

A number of hedge funds have recently added to or reduced their stakes in the business. Nolet Wealth Management LLC acquired a new position in shares of Ambev in the second quarter worth $42,000. Wynn Capital LLC boosted its holdings in Ambev by 3.7% in the second quarter. Wynn Capital LLC now owns 150,285 shares of the company’s stock valued at $472,000 after purchasing an additional 5,420 shares during the period. Global Wealth Strategies & Associates acquired a new position in Ambev during the 2nd quarter worth $37,000. Amundi increased its holdings in Ambev by 19.0% during the 1st quarter. Amundi now owns 587,232 shares of the company’s stock worth $1,715,000 after purchasing an additional 93,698 shares during the period. Finally, Royal Bank of Canada increased its holdings in Ambev by 18.1% during the 1st quarter. Royal Bank of Canada now owns 3,700,035 shares of the company’s stock worth $10,804,000 after purchasing an additional 566,949 shares during the period. 8.13% of the stock is currently owned by institutional investors and hedge funds.

About Ambev

Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.

The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.